{"disease":{"id":"infants","name":"infants"},"drugs":{"marketed":[{"drug_id":"prevnar-20","indication_name":"Active immunisation in infants, children, and adolescents (6 weeks to <18 years)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevnar 20","generic_name":"pneumococcal 20-valent conjugate vaccine (PCV20)","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae capsular polysaccharides (20 serotypes)","drug_class":"Pneumococcal conjugate vaccine","quality_score":80,"revenue":"6400","mechanism":"20-valent pneumococcal conjugate vaccine that elicits immune responses against 20 Streptococcus pneumoniae serotypes"},{"drug_id":"glutamic-acid","indication_name":"Nutritional Support for Infants and Young Children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glutamate","generic_name":"GLUTAMIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Glutamate dehydrogenase 1, mitochondrial, Glutamate dehydrogenase 2, mitochondrial, Metabotropic glutamate receptor 6","drug_class":"Amino Acid [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"histidine","indication_name":"Nutritional Support for Infants and Young Children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Histidine","generic_name":"HISTIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Large neutral amino acids transporter small subunit 1","drug_class":"Amino Acid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV disease due to prematurity.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Respiratory Syncytial Virus Prefusion F Subunit Vaccine","generic_name":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Respiratory Syncytial Virus (RSV)","drug_class":"Vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV disease due to certain chronic lung conditions.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Respiratory Syncytial Virus Prefusion F Subunit Vaccine","generic_name":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Respiratory Syncytial Virus (RSV)","drug_class":"Vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV disease due to certain heart conditions.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Respiratory Syncytial Virus Prefusion F Subunit Vaccine","generic_name":"respiratory-syncytial-virus-prefusion-f-subunit-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Respiratory Syncytial Virus (RSV)","drug_class":"Vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-vaccine","indication_name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV-associated hospitalization due to prematurity.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF Vaccine","generic_name":"rsvpref-vaccine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"RSV","drug_class":"vaccine","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-mdv","indication_name":"Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF MDV","generic_name":"rsvpref-mdv","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"RSV F protein","drug_class":"Monoclonal antibody","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"pediarix","indication_name":"Protection against diphtheria, tetanus, pertussis (whole-cell), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b (Hib) disease in infants and children from 6 weeks through 6 years of age.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pediarix","generic_name":"pediarix","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Immune system","drug_class":"vaccine","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"pediarix","indication_name":"Protection against diphtheria, tetanus, pertussis (whole-cell), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b (Hib) disease in infants and children from 6 weeks through 6 years of age, when used in a 3-dose series.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pediarix","generic_name":"pediarix","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Immune system","drug_class":"vaccine","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"infanrix","indication_name":"Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infanrix","generic_name":"infanrix","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"vaccine","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"rsvpref","indication_name":"Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF","generic_name":"rsvpref","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"RSV F protein","drug_class":"Monoclonal antibody","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"rsvpref-120-g","indication_name":"Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RSVpreF 120 µg","generic_name":"rsvpref-120-g","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prefusion form of the RSV F protein","drug_class":"Recombinant subunit vaccine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe atopic dermatitis in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe plaque psoriasis in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe hidradenitis suppurativa in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe erythromelalgia in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"alanine","indication_name":"Nutritional Support in Infants and Young Children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Alanine","generic_name":"ALANINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Amino Acid [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe intertrigo in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe vitiligo in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe alopecia areata in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe lichen simplex chronicus in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe pemphigus vulgaris in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe bullous pemphigoid in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe generalized pustular psoriasis in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe palmoplantar pustulosis in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe axillary hidradenitis suppurativa in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe anogenital pruritus in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe prurigo nodularis in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe lichen sclerosus in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe epidermolysis bullosa acquisita in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe mucous membrane pemphigoid in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe chronic spontaneous urticaria in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chronic-pf-06480605-450-mg-sc-q4w","indication_name":"Moderate to severe prurigo nodularis in infants and children","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chronic- PF-06480605 450 mg SC Q4W","generic_name":"chronic-pf-06480605-450-mg-sc-q4w","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"IL-4 receptor alpha subunit","drug_class":"pharmacological class not specified","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":34,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03079245","title":"Improving Antimicrobial Prescribing Practices in the Neonatal ICU","phase":"NA","overall_status":"COMPLETED","enrollment_count":6184,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT03703583","title":"Infant Feeding Practice and Gut Comfort Study","phase":"","overall_status":"COMPLETED","enrollment_count":2804,"lead_sponsor_name":"Société des Produits Nestlé (SPN)","has_results":false},{"nct_id":"NCT04555590","title":"Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":1882,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT03511118","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","phase":"","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03181958","title":"A Trial Comparing Noninvasive Ventilation Strategies in Preterm Infants Following Extubation","phase":"NA","overall_status":"COMPLETED","enrollment_count":1493,"lead_sponsor_name":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","has_results":true},{"nct_id":"NCT03327415","title":"Nutri-Bébé 2013 Survey on Food Consumption of Infants and Young Children","phase":"","overall_status":"COMPLETED","enrollment_count":1192,"lead_sponsor_name":"Secteur Français des Aliments de l'Enfance","has_results":false},{"nct_id":"NCT06262867","title":"Early Allergen System Experience","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1110,"lead_sponsor_name":"Prollergy dba Ready Set Food","has_results":false},{"nct_id":"NCT06332521","title":"Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment","phase":"","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT03722550","title":"Second Generation Human Milk Oligosaccharides Blend Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":789,"lead_sponsor_name":"Société des Produits Nestlé (SPN)","has_results":false},{"nct_id":"NCT07077941","title":"Comparing Integrative Midwife-led vs. Fragmented Inpatient Postpartum Care: Impact on Satisfaction and Transition to Motherhood","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":784,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT05849077","title":"Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)","phase":"NA","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT06544096","title":"Application Evaluation of Newborn Home Skin Care Management System Under the Service of \"WeChat Platform+Health Care\"","phase":"NA","overall_status":"COMPLETED","enrollment_count":692,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT06857539","title":"Assessing Intellectual and Motor Outcomes in High-risk Infants","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"University College Cork","has_results":false},{"nct_id":"NCT03309488","title":"Basophil Activation Test to Diagnose Food Allergy","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT06501404","title":"PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":583,"lead_sponsor_name":"José Antonio Hurtado Suazo","has_results":false},{"nct_id":"NCT06475521","title":"A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New Infant- and follow-on Formula for Healthy Term Infants.","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":579,"lead_sponsor_name":"Nutricia Research","has_results":false},{"nct_id":"NCT07280624","title":"Diagnostic PCR Panel in Children With Acute Gastrointestinal Symptoms","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":526,"lead_sponsor_name":"University of Oulu","has_results":false},{"nct_id":"NCT06993129","title":"A Multi-Site Hybrid Type I Effectiveness-Implementation Randomized Trial of an Emergency Care Action Plan for Infants With Medical Complexity","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Vermont","has_results":false},{"nct_id":"NCT06755424","title":"GI Symptoms in Infants Fed Goat Milk-based Infant Formula","phase":"","overall_status":"COMPLETED","enrollment_count":425,"lead_sponsor_name":"Ausnutria Hyproca B.V.","has_results":false},{"nct_id":"NCT04481191","title":"Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07532421","title":"Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06559020","title":"Predictors and Outcomes of Kangaroo Mother Care: A Quasi-Experimental Study in Pakistan","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Services Institute of Medical Sciences, Pakistan","has_results":false},{"nct_id":"NCT06287697","title":"Energy Expenditure and Body Composition of Infants and Young Children (6-24 Months Old) in Asia","phase":"","overall_status":"UNKNOWN","enrollment_count":391,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT07054216","title":"Probiotic for Infants","phase":"NA","overall_status":"RECRUITING","enrollment_count":378,"lead_sponsor_name":"Hvidovre University Hospital","has_results":false},{"nct_id":"NCT06987227","title":"Effects of Intelligent Parent-child Bonding Intervention on the Physical, Psychological and Social Health of Parents of Premature Infants During Hospitalization and Return Home","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"National Defense Medical Center, Taiwan","has_results":false},{"nct_id":"NCT03099694","title":"NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":340,"lead_sponsor_name":"Xingwang Zhu","has_results":true},{"nct_id":"NCT05265195","title":"PeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)","phase":"","overall_status":"UNKNOWN","enrollment_count":340,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT03423836","title":"Maternal Oral Therapy to Reduce Obstetric Risk Kids","phase":"","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04962594","title":"Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)","phase":"NA","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"Société des Produits Nestlé (SPN)","has_results":false},{"nct_id":"NCT05137340","title":"NIV-MISA-NRDS Trial: a Multicenter Study in China","phase":"NA","overall_status":"TERMINATED","enrollment_count":312,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04389606","title":"Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":311,"lead_sponsor_name":"ByHeart","has_results":false},{"nct_id":"NCT04218929","title":"Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":311,"lead_sponsor_name":"ByHeart","has_results":false},{"nct_id":"NCT07373002","title":"Development and Evaluation of an Intelligent Parent-Infant Connection-Based Intervention to Strengthen Family Resilience in Preterm Infant Care","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Defense Medical Center, Taiwan","has_results":false},{"nct_id":"NCT06318858","title":"Daily and Weekly Iron Supplementation in Infants","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT06687044","title":"Sleep Improvement Therapy Affects Pregnancy Outcomes in Chinese Singletons and Twins by Improving Sleep Quality","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Jun Wei","has_results":false},{"nct_id":"NCT05230706","title":"Light/Dark Cycle Promotes Weight Gain in Preterm Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Universidad Nacional Autonoma de Mexico","has_results":false},{"nct_id":"NCT05076461","title":"Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Tehsil Headquarter Hospital","has_results":false},{"nct_id":"NCT03187938","title":"Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight","phase":"","overall_status":"COMPLETED","enrollment_count":292,"lead_sponsor_name":"TriHealth Inc.","has_results":false},{"nct_id":"NCT03520764","title":"To Investigate Effects of a New Infant Formula in Healthy Term Chinese Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Danone Nutricia","has_results":false},{"nct_id":"NCT04015050","title":"Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.","phase":"NA","overall_status":"COMPLETED","enrollment_count":279,"lead_sponsor_name":"Nutricia Research","has_results":false},{"nct_id":"NCT06092463","title":"The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease","phase":"","overall_status":"RECRUITING","enrollment_count":275,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06601114","title":"The Effectiveness of Paracetamol Versus Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Neonates","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":254,"lead_sponsor_name":"Arooj Khan","has_results":false},{"nct_id":"NCT03000543","title":"Novel Isotope Dilution Technique to Assess Vitamin A Status","phase":"NA","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT06707376","title":"Early Kangaroo Care vs. Standard Neonatal Practices: Impact on Survival and Outcomes in Preterm Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Jouf University","has_results":false},{"nct_id":"NCT04740515","title":"Influence of a PPMTM on Adherence and Clinical Outcomes Among Preterm Infants With Iron Supplementation","phase":"NA","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Shaoxing Maternity and Child Health Care Hospital","has_results":false},{"nct_id":"NCT07350018","title":"Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":234,"lead_sponsor_name":"Uludag University","has_results":false},{"nct_id":"NCT04017520","title":"Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":221,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT03109223","title":"Addition to Infant Formula of 2-fucosyllactose (2-FL)","phase":"NA","overall_status":"COMPLETED","enrollment_count":221,"lead_sponsor_name":"PBM Nutritionals","has_results":false},{"nct_id":"NCT04318847","title":"Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":220,"lead_sponsor_name":"Lizar Aguirre Pascasio","has_results":false},{"nct_id":"NCT04801823","title":"The TreEat Study- Can Early Introduction of Tree Nuts Prevent Tree Nut Allergy in Infants With Peanut Allergy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":212,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}